Optimized outcome of the Ross procedure in children: single-centre experience
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf102 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Peter Murin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital Heart Surgery-Pediatric Heart Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany. Hauptthemen laut MEDLINE: Pulmonary Valve, Aortic Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES The Ross procedure with autograft reinforcement has been proposed as a strategy to prevent autograft failure in adults, but outcome data in children during somatic growth remain limited. We investigated long-term outcomes following an individualized autograft reinforcement protocol to evaluate survival and reintervention rates. METHODS Between January 1995 and December 2022, 233 patients <18 years [median age: 7 (1–13) years] underwent the Ross procedure, including 60 infants (26%). Most frequently free-root autograft implantation without reinforcement was performed (n = 156, 67%). Autograft reinforcement was applied in 77 patients (33%) using either subcoronary implantation (n = 65, 28%) or external prosthetic support (n = 12, 5%). Kaplan–Meier survival estimates were used for survival and reintervention analyses. Risk factors for reintervention were identified by Cox proportional hazards regression. RESULTS Reinforcement was associated with improved survival (5-year survival rates of 97.1% vs 87.0%, 10-year survival rates of 97.1% versus 86.99%, P = 0.017). No differences in autograft reintervention between the groups were found (1-year rates of 100% vs 99.4%, 5-year rates of 100%, P = 0.4852). Right ventricle–pulmonary artery (RV-PA) reintervention-free survival at 5 years was higher for homografts compared to xenografts (96.9% vs 79.4%, P < 0.001). CONCLUSIONS The Ross procedure in children demonstrated excellent long-term outcomes with low autograft reintervention rates in both groups. Reinforcement was associated with improved long-term survival while autograft-related reinterventions did not differ significantly between groups. Older age at Ross and homograft use correlated with lower RV-PA reintervention risk. Multicentre evaluation of reinforcement techniques is required to assess the outcome differences observed in this single-centre experience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Congenital Heart Surgery-Pediatric Heart Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
- Department of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
- Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany.
Zitieren
APA
Murin, P., Gaal, J., Stenzel, R., Weixler, V., Romanchenko, O., Seiler, R., Ovroutski, S., Berger, F., Cho, M. Y., Photiadis, J., & Kelm, M. (2025). Optimized outcome of the Ross procedure in children: single-centre experience. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf102
Vancouver
Murin P, Gaal J, Stenzel R, Weixler V, Romanchenko O, Seiler R, et al. Optimized outcome of the Ross procedure in children: single-centre experience. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf102
BibTeX
@article{Murin2025,
author = {Murin, Peter and Gaal, Julia and Stenzel, Robin and Weixler, Viktoria and Romanchenko, Olga and Seiler, Raphael and Ovroutski, Stanislav and Berger, Felix and Cho, Mi-Young and Photiadis, Joachim and Kelm, Marcus},
title = {Optimized outcome of the Ross procedure in children: single-centre experience},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf102}
}
EUVIMED